OSLO, Norway, Jan. 20, 2014 (GLOBE NEWSWIRE) -- Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, announces an update to its financial calendar.
The fourth quarter and full year 2013 results will now be published on 5 February 2014, and not on 28 February 2014 as stated in the announcement of 6 November 2013.
For further information, please contact:
|Oystein Soug||+47 90 65 65 25|
|Chief Financial Officer|
|Mike Booth||+1 646 410 1884|
|Communications & Corporate Affairsfirstname.lastname@example.org|
Algeta is a company focused on developing, manufacturing and marketing novel targeted therapies for patients with cancer. The company is headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA performing commercial marketing operations in the US. Algeta is listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information please visit www.algeta.com .
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Change to financial calendar http://hugin.info/134655/R/1755608/592808.pdf